These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 5380020)

  • 41. Treprostinil (Remodulin) for pulmonary arterial hypertension.
    Med Lett Drugs Ther; 2002 Sep; 44(1139):80-2. PubMed ID: 12237619
    [No Abstract]   [Full Text] [Related]  

  • 42. Viagra shows potential as a cardiopulmonary drug. Vasodilatory effects improve heart and lung function by increasing circulation and relaxing blood vessels.
    Health News; 2006 Mar; 12(3):3-4. PubMed ID: 16532564
    [No Abstract]   [Full Text] [Related]  

  • 43. Management of severe pulmonary hypertension during surgery for congenital heart disease.
    Shyamkrishnan KG; Waikar HD; Titus T
    Indian Heart J; 1996; 48(2):159-60. PubMed ID: 8682557
    [No Abstract]   [Full Text] [Related]  

  • 44. Sildenafil in neonatal pulmonary hypertension due to impaired alveolarisation and plexiform pulmonary arteriopathy.
    Chaudhari M; Vogel M; Wright C; Smith J; Haworth SG
    Arch Dis Child Fetal Neonatal Ed; 2005 Nov; 90(6):F527-8. PubMed ID: 16244212
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The pathology of primary pulmonary hypertension.
    Burke AP; Farb A; Virmani R
    Mod Pathol; 1991 Mar; 4(2):269-82. PubMed ID: 2047387
    [No Abstract]   [Full Text] [Related]  

  • 46. [Primary pulmonary hypertension].
    Simarro E; Barriales V
    Med Clin (Barc); 1988 Mar; 90(11):469-73. PubMed ID: 3290596
    [No Abstract]   [Full Text] [Related]  

  • 47. Rationale for the judicious use of placebos in PAH trials.
    White RJ; Hiremath J
    J Heart Lung Transplant; 2010 Jul; 29(7):826-7. PubMed ID: 20471863
    [No Abstract]   [Full Text] [Related]  

  • 48. [Treatment of primary pulmonary hypertension with vasodilator drugs].
    Rigau D; Agustí A
    Med Clin (Barc); 2003 Feb; 120(5):194-6. PubMed ID: 12605828
    [No Abstract]   [Full Text] [Related]  

  • 49. Pulmonary hypertension, right ventricular failure, and vasodilator therapy. Making pathophysiologic sense.
    Davila F
    Chest; 1986 Sep; 90(3):467-8. PubMed ID: 3743174
    [No Abstract]   [Full Text] [Related]  

  • 50. Plexogenic pulmonary hypertension of unknown origin. What's new?
    Lockhart A; Reeves JT
    Clin Sci (Lond); 1984 Jul; 67(1):1-5. PubMed ID: 6375936
    [No Abstract]   [Full Text] [Related]  

  • 51. Pulmonary vasodilators in postoperative pulmonary hypertension.
    Kashani IA; Swensson RE
    Am Heart J; 1983 Oct; 106(4 Pt 1):778-9. PubMed ID: 6613826
    [No Abstract]   [Full Text] [Related]  

  • 52. Long-term clinical trials in pulmonary hypertension. Long overdue.
    Theodore J; Burke CM
    Chest; 1986 Jan; 89(1):4-5. PubMed ID: 3510108
    [No Abstract]   [Full Text] [Related]  

  • 53. [Vasotropic therapy and artificial respiration for pulmonary hypertension].
    Grimminger F; Olschewski H; Seeger W
    Internist (Berl); 1999 Jul; 40(7):747-55. PubMed ID: 10429917
    [No Abstract]   [Full Text] [Related]  

  • 54. Papaverine, a vasodilator with antiviral activity.
    Koch HJ; Raschka C
    Swiss Med Wkly; 2002 Feb; 132(7-8):105; author reply 105. PubMed ID: 11971205
    [No Abstract]   [Full Text] [Related]  

  • 55. Current trends in research and clinical trials of drugs for chronic pulmonary hypertension.
    Morpurgo M; Jezek V
    Eur Heart J; 1988 Sep; 9 Suppl J():39-43. PubMed ID: 3053184
    [No Abstract]   [Full Text] [Related]  

  • 56. Variable Monitoring of Veterans with Group 3 Pulmonary Hypertension Treated with Off-Label Pulmonary Vasodilator Therapy.
    Johnson SW; Gillmeyer KR; Bolton RE; McCullough MB; Qian SX; Maron BA; Klings ES; Wiener RS
    Ann Am Thorac Soc; 2022 Jul; 19(7):1236-1239. PubMed ID: 35312466
    [No Abstract]   [Full Text] [Related]  

  • 57. [Primary hypertension of lesser circulation].
    SOVA J; PECHAR J; SIMANE J; FEIX C
    Cas Lek Cesk; 1952 Mar; 91(10):293-7. PubMed ID: 14390149
    [No Abstract]   [Full Text] [Related]  

  • 58. [Vasodilator agents in the treatment of hypertension of the lesser circulation].
    Zaslavskaia RM
    Klin Med (Mosk); 1969 Nov; 47(11):120-6. PubMed ID: 5380020
    [No Abstract]   [Full Text] [Related]  

  • 59. [Pharmacological aspects within the scope of pulmonary hypertension].
    Kraupp O
    Med Welt; 1972 Jul; 23(29):1006-8. PubMed ID: 5077680
    [No Abstract]   [Full Text] [Related]  

  • 60. Treatment of chronic pulmonary hypertension by vasodilators. Symposium: E.S.C. Working Group on Pulmonary Circulation. 9 September 1987, Santiago de Compostela, Spain.Proceedings.
    Eur Heart J; 1988 Sep; 9 Suppl J():1-43. PubMed ID: 3181181
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.